Efficacy of Co-Spinal Ondansetron In Inguinal Herniorrhaphy
Status:
ENROLLING_BY_INVITATION
Trial end date:
2025-08-15
Target enrollment:
Participant gender:
Summary
Ondansetron, a selective serotonin 5-HT3 receptor antagonist, is well known for its antiemetic effects. However, its ability to reduce hypotension during spinal anesthesia has recently sparked great interest. In clinical practice, administering ondansetron before spinal anesthesia has produced promising results.